Kentaro Ohara Selected Research

Kentaro Ohara Research Topics

Disease

25	Neoplasms (Cancer) 05/2022 - 05/2013
6	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 08/2016
4	Glioma (Gliomas) 12/2021 - 08/2016
4	Meningioma (Meningiomas) 04/2021 - 12/2018
3	Carcinoma (Carcinomatosis) 01/2022 - 11/2013
3	Brain Neoplasms (Brain Tumor) 01/2021 - 08/2018
3	Neoplasm Metastasis (Metastasis) 09/2018 - 01/2017
2	Chordoma 01/2021 - 08/2019
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2020 - 12/2019
2	Fever (Fevers) 04/2019 - 01/2016
2	Hypoxia (Hypoxemia) 12/2018 - 11/2017
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2013
1	Microsatellite Instability 11/2021
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2021
1	Hepatitis 10/2020
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020
1	Neurilemmoma (Schwannoma) 12/2019
1	Infections 04/2019
1	Histoplasmosis 04/2019
1	Miliary Tuberculosis 04/2019
1	Eczematous Skin Diseases 04/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2018
1	Thrombosis (Thrombus) 04/2017
1	Wounds and Injuries (Trauma) 04/2017
1	Chondrosarcoma 01/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Leukocytosis (Pleocytosis) 01/2016
1	Aneurysm (Aneurysms) 11/2012
1	Microaneurysm 11/2012
1	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2012
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2009
1	Edema (Dropsy) 09/2009
1	Hepatic Encephalopathy 09/2009

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 08/2016
5	NestinIBA 12/2021 - 08/2016
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 12/2018
5	Bevacizumab (Avastin)FDA Link 12/2019 - 08/2016
3	Immune Checkpoint ProteinsIBA 01/2020 - 12/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2021 - 08/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 10/2020
2	RNA (Ribonucleic Acid)IBA 08/2021 - 01/2021
2	ParaffinIBA 08/2021 - 04/2021
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 09/2019
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 08/2018
2	VaccinesIBA 01/2020 - 12/2019
2	Metalloproteases (Metalloproteinases)IBA 01/2016 - 11/2013
2	DisintegrinsIBA 01/2016 - 11/2013
1	Discoidin Domain Receptor 2IBA 05/2022
1	pembrolizumabIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 12/2021
1	Alkylating AgentsIBA 12/2021
1	SolutionsIBA 11/2021
1	NucleotidesIBA 11/2021
1	Circulating Tumor DNAIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 11/2021
1	Formaldehyde (Formol)FDA Link 08/2021
1	trichrome stainIBA 04/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Messenger RNA (mRNA)IBA 10/2020
1	MethyltransferasesIBA 03/2020
1	Protein Subunit VaccinesIBA 12/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2019
1	Brachyury protein (Brachyury)IBA 08/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2019
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2019
1	Minocycline (Cyclops)FDA LinkGeneric 04/2019
1	Prednisolone (Predate)FDA LinkGeneric 04/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2019
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2019
1	Micafungin (FK463)FDA Link 04/2019
1	Meropenem (Merrem)FDA LinkGeneric 04/2019
1	Carbonic Anhydrase IXIBA 11/2017
1	Hypoxia-Inducible Factor 1IBA 11/2017
1	cariporideIBA 01/2017
1	AntibodiesIBA 01/2016
1	AcidsIBA 05/2013
1	TRPP Cation ChannelsIBA 11/2012
1	N-Methylaspartate (NMDA)IBA 09/2009
1	Glutamic Acid (Glutamate)FDA Link 09/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2009

Therapy/Procedure

8	Therapeutics 11/2021 - 08/2016
1	Drug Therapy (Chemotherapy) 12/2021
1	Canes (Cane) 11/2021
1	Immunotherapy 09/2019
1	Radiotherapy 12/2018
1	Time-to-Treatment 09/2018
1	Decompression 04/2017
1	Craniotomy 04/2017
1	Ventriculoperitoneal Shunt 04/2017
1	Surgical Amputation (Amputations) 01/2017
1	Injections 11/2013